United States · FDA National Drug Code directory

Niacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 59651-019_8539231f-47da-402e-b05d-16c45cc3670c
Product NDC: 59651-019
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Niacin
Labeler: Aurobindo Pharma Limited
Marketing category: ANDA
Marketing start / end (source format): 20180201
Source listing expiry: 20261231

Source-listed ingredients

NIACIN — 750 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-019-05) · 59651-019-05
180 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-019-18) · 59651-019-18
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-019-90) · 59651-019-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →